BOSTON SCIENTIFIC CORP

LUNG

BOSTON SCIENTIFIC CORP serves as 10% Owner at Pulmonx Corporation (LUNG). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$177.04M

Net Position

Net Seller

$177.04M

Companies Traded

LUNG

Active Period

Apr 2021 – Jul 2021

3 total trades

Most Recent

Sell LUNG

Jul 14, 2021 · $93.63M

BOSTON SCIENTIFIC CORP's Insider Trading at Pulmonx Corporation (LUNG)

Buys

0 · $0.00

Sells

3 · $177.04M

Total Shares Bought

Total Shares Sold

4,500,000

LUNG Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 14, 2021	Sell	2,500,000	$37.45	$93.63M	1,488,106
Apr 8, 2021	Sell	650,000	$43.60	$28.34M	3,988,106
Apr 1, 2021	Sell	1,350,000	$40.80	$55.08M	4,638,106

Related Insiders

Glendon E. French III

President and CEO

LUNGSell · Sep 3, 2026

David Aaron Lehman

officer: General Counsel

LUNGSell · Sep 3, 2026

Srikanth Radhakrishnan

officer: Chief Science & Techn. Officer

LUNGSell · Sep 3, 2026

Geoffrey Beran Rose

officer: Chief Commercial Officer

LUNGSell · Sep 3, 2026

Daniel P Florin

Director

LUNGSell · Dec 8, 2025

Explore More Insider Trading Data

LUNG Insider Trading Activity

View all insider trades at Pulmonx Corporation

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity